Login to Your Account

Financings Roundup

Monday, June 18, 2012
• Oxygen Biotherapeutics Inc., of Morrisville, N.C., said it entered agreements with institutional investors to amend the terms of its $7.5 million offering of registered shares of Series A convertible preferred stock and registered warrants to purchase shares.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription